Evidence map›Paper›PMID 36519329›Full record

ArticleHaematologica2023

Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.

Fabian Knörr, Kim P J Schellekens, Reineke A Schoot, Judith Landman-Parker, Heiko-Manuel Teltschik, Jan Förster, Amambay Riquelme, Alwin D R Huitema, Natasha K A Van Eijkelenburg, Auke Beishuizen and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Fabian KnörrPediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg. f.knoerr@uke.de.
Kim P J SchellekensPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
Reineke A SchootPrincess Máxima Center for Pediatric Oncology, Utrecht.
Judith Landman-ParkerPediatric Hematology, Immunology, Oncology, Sorbonne université, Hôpital Armand Trousseau, APHP, Paris.
Heiko-Manuel TeltschikPediatrics 5 (Oncology, Hematology, and Immunology), Olgahospital, Stuttgart.
Jan FörsterPediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Amambay RiquelmePediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Alwin D R HuitemaPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Dept. Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Dept. Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht.
Natasha K A Van EijkelenburgPrincess Máxima Center for Pediatric Oncology, Utrecht.
Auke BeishuizenPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
C Michel ZwaanPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
Wilhelm WoessmannPediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Jasper Van der LugtPrincess Máxima Center for Pediatric Oncology, Utrecht.

Funding

Cancer Research UK 25642
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Large-Cell, AnaplasticVinblastineAnaplastic Lymphoma KinaseChildCrizotinibHumansReceptor Protein-Tyrosine KinasesAnaplastic Lymphoma KinaseCrizotinibReceptor Protein-Tyrosine KinasesVinblastine

Identifiers

PMID36519329
PMCPMC10153539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.